Eton Pharmaceuticals Inc (NASDAQ: ETON) announced it has obtained U.S. commercialization rights to HEMANGEOL oral solution from Pierre Fabre Medicament ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE